For people with overweight or obesity and pre-existing cardiovascular disease (CVD), taking semaglutide for three years resulted in 20% fewer heart attacks, strokes, and deaths, compared to those taking a placebo, according to the new study
Physicians noticed a pleasant side effect of the medication: significant weight loss and long-term weight management benefits
Editorial: Lifestyle interventions for childhood obesity: Broadening the reach and scope of impact
Very low-fat diets may paradoxically increase gallstone risk by allowing bile to become concentrated in a poorly contracting gallbladder
Kuno et al., 2008), altering the expression of MRP2 (Qadri et al., 2009) and organic anion transporter 3 (OAT3) (Wang et al., 2018), or displacing MPA protein binding (Morassi et al., 2018)
Trgt zu einer normalen Funktion des Nervensystems bei